|
![spacer](https://webarchive.library.unt.edu/eot2008/20090121161056im_/http://www.cdc.gov/hiv/images/TemplateImages/s.gif) |
![spacer](https://webarchive.library.unt.edu/eot2008/20090121161056im_/http://www.cdc.gov/hiv/images/TemplateImages/s.gif) |
![spacer](https://webarchive.library.unt.edu/eot2008/20090121161056im_/http://www.cdc.gov/hiv/images/TemplateImages/s.gif) |
|
![Skip Nav](https://webarchive.library.unt.edu/eot2008/20090121161056im_/http://www.cdc.gov/hiv/images/TemplateImages/s.gif) |
![spacer](https://webarchive.library.unt.edu/eot2008/20090121161056im_/http://www.cdc.gov/hiv/images/TemplateImages/s.gif)
![spacer](https://webarchive.library.unt.edu/eot2008/20090121161056im_/http://www.cdc.gov/hiv/images/TemplateImages/s.gif) |
Table 13. Proportion of persons surviving for more than 12, 24, and 36 months after an AIDS diagnosis in 2001, by selected characteristics—United States and dependent areas |
![spacer](https://webarchive.library.unt.edu/eot2008/20090121161056im_/http://www.cdc.gov/hiv/images/TemplateImages/s.gif) |
![spacer](https://webarchive.library.unt.edu/eot2008/20090121161056im_/http://www.cdc.gov/hiv/images/TemplateImages/s.gif) |
View PDF
|
|
![](https://webarchive.library.unt.edu/eot2008/20090121161056im_/http://www.cdc.gov/hiv/images/s.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090121161056im_/http://www.cdc.gov/hiv/images/s.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090121161056im_/http://www.cdc.gov/hiv/images/s.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090121161056im_/http://www.cdc.gov/hiv/images/s.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090121161056im_/http://www.cdc.gov/hiv/images/s.gif) |
|
Survival in months |
|
>12 |
>24 |
>36 |
|
No. of persons |
|
Data for 50 states and the District of Columbia |
|
|
|
|
Age at diagnosis (yrs) |
|
|
|
|
<13 |
110 |
0.95 |
0.95 |
0.95 |
13–14 |
77 |
1.00 |
1.00 |
0.99 |
15–19 |
259 |
0.97 |
0.94 |
0.92 |
20–24 |
1,255 |
0.96 |
0.93 |
0.90 |
25–29 |
3,038 |
0.95 |
0.92 |
0.90 |
30–34 |
5,878 |
0.94 |
0.91 |
0.88 |
35–39 |
8,095 |
0.93 |
0.90 |
0.87 |
40–44 |
6,922 |
0.91 |
0.87 |
0.84 |
45–49 |
4,969 |
0.89 |
0.84 |
0.81 |
50–54 |
2,895 |
0.87 |
0.83 |
0.79 |
55–59 |
1,395 |
0.83 |
0.77 |
0.74 |
60–64 |
720 |
0.79 |
0.73 |
0.70 |
>65 |
648 |
0.70 |
0.63 |
0.59 |
|
|
|
|
|
Race/ethnicity |
|
|
|
|
White, not Hispanic |
10,482 |
0.92 |
0.88 |
0.86 |
Black, not Hispanic |
18,543 |
0.90 |
0.86 |
0.82 |
Hispanic |
6,512 |
0.93 |
0.90 |
0.88 |
Asian/Pacific Islander |
355 |
0.90 |
0.88 |
0.87 |
American Indian/Alaska Native |
150 |
0.86 |
0.82 |
0.77 |
|
|
|
|
|
Transmission category |
|
|
|
|
Male adult or adolescent |
|
|
|
|
Male-to-male sexual contact |
12,468 |
0.93 |
0.90 |
0.88 |
Injection drug use |
4,384 |
0.88 |
0.83 |
0.79 |
Male-to-male sexual contact and injection drug use |
1,738 |
0.93 |
0.89 |
0.84 |
High-risk heterosexual contacta |
2,985 |
0.91 |
0.88 |
0.86 |
Otherb |
4,977 |
0.87 |
0.83 |
0.81 |
Subtotal |
26,552 |
0.91 |
0.87 |
0.85 |
|
|
|
|
|
Female adult or adolescent |
|
|
|
|
Injection drug use |
2,254 |
0.90 |
0.84 |
0.78 |
High-risk heterosexual contacta |
4,587 |
0.93 |
0.89 |
0.86 |
Otherb |
2,758 |
0.90 |
0.86 |
0.83 |
Subtotal |
9,599 |
0.91 |
0.87 |
0.83 |
|
|
|
|
|
Child (<13 yrs at diagnosis) |
|
|
|
|
Perinatal |
96 |
0.95 |
0.95 |
0.95 |
Otherc |
14 |
1.00 |
1.00 |
1.00 |
Subtotal |
110 |
0.95 |
0.95 |
0.95 |
|
|
|
|
|
Subtotal for 50 states and the District of Columbia |
36,261 |
0.91 |
0.87 |
0.84 |
|
|
|
|
|
Data for U.S. dependent areas |
1,013 |
0.82 |
0.78 |
0.75 |
|
|
|
|
|
Total |
37,325d |
0.91 |
0.87 |
0.84 |
|
![](https://webarchive.library.unt.edu/eot2008/20090121161056im_/http://www.cdc.gov/hiv/images/s.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090121161056im_/http://www.cdc.gov/hiv/images/s.gif) |
Note. Excludes persons whose date of death was before, or in the same month as, date of diagnosis. Excludes persons whose month of diagnosis or month of death is unknown. |
a |
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection. |
b |
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified. |
c |
Includes hemophilia, blood transfusion, and risk factor not reported or not identified. |
d |
Includes 221 persons of unknown race or multiple races. |
|
Next: Figure 2 |
|
|
|
|
|
![spacer](https://webarchive.library.unt.edu/eot2008/20090121161056im_/http://www.cdc.gov/hiv/images/TemplateImages/s.gif) |
|
|